AC
BAK icon

Avestar Capital’s Braskem BAK Stock Holding History

Avestar Capital’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16
Closed – – 856
2019
Q1 		$0 Hold
16
– – ﹤0.01% 842
2018
Q4 		$0 Buy
+16
New +$434 ﹤0.01% 839

Other funds holding BAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Avestar Capital's BAK Position: Q2 2019 in Review

Avestar Capital sold out of Braskem (BAK) in Q2 2019, closing a stake of 16 shares.

Avestar Capital first reported a position in BAK in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 17 funds tracked by Wall St. Rank hold BAK as of Q2 2019.

  • Avestar Capital reported no remaining Braskem position as of Q2 2019 after selling out during the quarter.
  • Avestar Capital sold 16 Braskem shares in Q2 2019.
  • Avestar Capital first reported a position in Braskem in Q4 2018 and held it in 2 quarters.
  • Avestar Capital's Braskem position peaked at $0 in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Braskem as of Q2 2019.

Based on Avestar Capital's 13F filing for Q2 2019, filed 6 Aug 2019.